Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Clinical trial NCT02743351 · COMPLETED

Trial details

NCT number: NCT02743351
Sponsor: Fate Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Acute Graft-versus-host Disease

Start date: 2016-12-20
Primary completion: 2020-12-04
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.